Literature DB >> 15019425

Cocaine effects on the developing brain: current status.

John A Harvey1.   

Abstract

The present paper reports on the results obtained in a rabbit model of prenatal cocaine exposure that mimics the pharmacokinetics of crack cocaine in humans, and relates these findings to studies in other species including humans. A general finding is that prenatal exposure to cocaine during neurogenesis produces dysfunctions in signal transduction via the dopamine D(1) receptor and alterations in cortical neuronal development leading to permanent morphological abnormalities in frontocingulate cortex and other brain structures. Differences in the precise effects obtained appear to be due to the dose, route and time of cocaine administration. Related to these effects of in utero cocaine exposure, animals demonstrate permanent deficits in cognitive processes related to attentional focus that have been correlated with impairment of stimulus processing in the anterior cingulate cortex. The long-term cognitive deficits observed in various species are in agreement with recent reports indicating that persistent attentional and other cognitive deficits are evident in cocaine-exposed children as they grow older and are challenged to master more complex cognitive tasks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019425     DOI: 10.1016/j.neubiorev.2003.11.006

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  49 in total

1.  Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters.

Authors:  Lokman Torun; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2012-02-08       Impact factor: 3.641

2.  Early adolescent cocaine use as determined by hair analysis in a prenatal cocaine exposure cohort.

Authors:  Tamara Duckworth Warner; Marylou Behnke; Fonda Davis Eyler; Nancy J Szabo
Journal:  Neurotoxicol Teratol       Date:  2010-07-18       Impact factor: 3.763

3.  Gender differences in prodynorphin but not proenkephalin mRNA expression in the striatum of adolescent rats exposed to prenatal cocaine.

Authors:  Annelyn Torres-Reveron; Yasmin L Hurd; Diana L Dow-Edwards
Journal:  Neurosci Lett       Date:  2007-05-05       Impact factor: 3.046

Review 4.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

Review 5.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

Review 6.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

7.  Prenatal cocaine exposure: drug and environmental effects at 9 years.

Authors:  Lynn T Singer; Suchitra Nelson; Elizabeth Short; Meeyoung O Min; Barbara Lewis; Sandra Russ; Sonia Minnes
Journal:  J Pediatr       Date:  2008-03-06       Impact factor: 4.406

Review 8.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

9.  SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation.

Authors:  Michael Weed; Robert J Adams; Robert D Hienz; Kelly A Meulendyke; Michael E Linde; Janice E Clements; Joseph L Mankowski; M Christine Zink
Journal:  J Neuroimmune Pharmacol       Date:  2011-05-28       Impact factor: 4.147

10.  Longitudinal changes of amygdala and default mode activation in adolescents prenatally exposed to cocaine.

Authors:  Zhihao Li; Claire D Coles; Mary Ellen Lynch; Yuejia Luo; Xiaoping Hu
Journal:  Neurotoxicol Teratol       Date:  2015-11-11       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.